SunilJeramAdvaniMD
Radiation Oncology • La Jolla, CAAssistant Professor, Radiation Medicine and Applied Sciences, UCSD School of Medicine
Dr. Advani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr 843
UCSD Moores Cancer Center Dept Radiation Oncology
La Jolla, CA 92093Phone+1 858-822-4364Fax+1 858-822-7400
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2005 - 2009
Oregon Health Science University HospitalInternship, Transitional Year, 2004 - 2005
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
OR State Medical License 2004 - Present
CA State Medical License 2009 - 2025
IL State Medical License 2008 - 2009
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- NIH/NCI R37 MERIT Award NIH/NCI
Publications & Presentations
PubMed
- Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment.Mahsa Mortaja, Marcus M Cheng, Alina Ali, Jacqueline Lesperance, Dina V Hingorani
Molecules. 2024-11-27 - 25 citationsMonomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy.Dina V Hingorani, Michael M Allevato, Maria F Camargo, Jacqueline Lesperance, Maryam A Quraishi
Nature Communications. 2022-07-05 - 15 citationsA FZD7-specific antibody-drug conjugate induces ovarian tumor regression in preclinical modelsMyan Do, Christina C.N. Wu, Pooja R Sonavane, Edwin F. Juarez, Stephen R. Adams
Molecular Cancer Therapeutics. 2021-10-19
Press Mentions
LJI Scientists Receive Curebound Funding to Advance Cancer ResearchMarch 17th, 2025
Grant Support
- Spatially precise radio-chemo-immunotherapy using antibody conjugatesUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Spatially precise radio-chemo-immunotherapy using antibody conjugatesUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Elucidation and therapeutic exploitation of PAK mediated radioresistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2017–2025
Research History
- Post-Doctoral Research FellowMolecular Virology1999 - 2004
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
